BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Covaceuszach S, Bozzi M, Bigotti MG, Sciandra F, Konarev PV, Brancaccio A, Cassetta A. Structural flexibility of human α-dystroglycan. FEBS Open Bio 2017;7:1064-77. [PMID: 28781947 DOI: 10.1002/2211-5463.12259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Arefin A, Ismail Ema T, Islam T, Hossen S, Islam T, Al Azad S, Uddin Badal N, Islam A, Biswas P, Alam NU, Islam E, Anjum M, Masud A, Kamran S, Rahman A, Kumar Paul P. Target specificity of selective bioactive compounds in blocking α-dystroglycan receptor to suppress Lassa virus infection: an in silico approach. J Biomed Res 2021;35:459-73. [PMID: 34857680 DOI: 10.7555/JBR.35.20210111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Strelnikov VV, Kuznetsova EB, Tanas AS, Rudenko VV, Kalinkin AI, Poddubskaya EV, Kekeeva TV, Chesnokova GG, Trotsenko ID, Larin SS, Kutsev SI, Zaletaev DV, Nemtsova MV, Simonova OA. Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer. Sci Rep 2021;11:2264. [PMID: 33500458 DOI: 10.1038/s41598-021-81851-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
3 Righino B, Bozzi M, Pirolli D, Sciandra F, Bigotti MG, Brancaccio A, De Rosa MC. Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1. J Chem Inf Model 2020;60:3145-56. [PMID: 32356985 DOI: 10.1021/acs.jcim.0c00281] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Brancaccio A. A molecular overview of the primary dystroglycanopathies. J Cell Mol Med 2019;23:3058-62. [PMID: 30838779 DOI: 10.1111/jcmm.14218] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
5 Rudenko G. Neurexins - versatile molecular platforms in the synaptic cleft. Curr Opin Struct Biol 2019;54:112-21. [PMID: 30831539 DOI: 10.1016/j.sbi.2019.01.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
6 König E, Volpato CB, Motta BM, Blankenburg H, Picard A, Pramstaller P, Casella M, Rauhe W, Pompilio G, Meraviglia V, Domingues FS, Sommariva E, Rossini A. Exploring digenic inheritance in arrhythmogenic cardiomyopathy. BMC Med Genet 2017;18:145. [PMID: 29221435 DOI: 10.1186/s12881-017-0503-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Signorino G, Covaceuszach S, Bozzi M, Hübner W, Mönkemöller V, Konarev PV, Cassetta A, Brancaccio A, Sciandra F. A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. Hum Mutat 2018;39:266-80. [PMID: 29134705 DOI: 10.1002/humu.23370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 . Préclinique. Med Sci (Paris) 2017;33 Hors série n°1:58-60. [PMID: 29139390 DOI: 10.1051/medsci/201733s113] [Reference Citation Analysis]
9 Covaceuszach S, Bozzi M, Bigotti MG, Sciandra F, Konarev PV, Brancaccio A, Cassetta A. The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of α-dystroglycan. PLoS One 2017;12:e0186110. [PMID: 29036200 DOI: 10.1371/journal.pone.0186110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]